Transgenic mice expressing a Huntington s disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: In: Proceedings of the National Academy of Sciences ; 96 (1999), 15. - S. 8727-8732. - ISSN 0027-8424. - eISSN 1091-6490

Keyword: Biopharmazie
Pharmakodynamik
Pharmakokinetik

Event: Veröffentlichung

(where): Konstanz

(who): Bibliothek der Universität Konstanz

(when): 2009

Creator: Hansson, Oskar
Petersén, Åsa
Leist, Marcel
Nicotera, Pierluigi
Castilho, Roger F.
Brundin, Patrik

URN: urn:nbn:de:bsz:352-opus-82337

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:00 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Hansson, Oskar
Petersén, Åsa
Leist, Marcel
Nicotera, Pierluigi
Castilho, Roger F.
Brundin, Patrik
Bibliothek der Universität Konstanz

Time of origin

2009

Other Objects (12)

Effects of certain pre-analytical factors on the performance of plasma phospho-tau217

Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease

Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer’s disease

Characterization of degradation and heterozygote balance by simulation of the forensic DNA analysis process

External validation of a 3-step falls prediction model in mild Parkinson’s disease

Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies

Novel insights regarding the measurement properties of the SCOPA-AUT

Towards a unified protocol for handling of CSF before β-amyloid measurements

Publisher Correction: Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies

Fluid biomarkers in Alzheimer’s disease – current concepts

The clinical significance of 10-m walk test standardizations in Parkinson’s disease

Factors associated with fear of falling in people with Parkinson’s disease

Effects of certain pre-analytical factors on the performance of plasma phospho-tau217

Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease

Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer’s disease

Characterization of degradation and heterozygote balance by simulation of the forensic DNA analysis process

External validation of a 3-step falls prediction model in mild Parkinson’s disease

Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies

Novel insights regarding the measurement properties of the SCOPA-AUT

Towards a unified protocol for handling of CSF before β-amyloid measurements

Publisher Correction: Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies

Fluid biomarkers in Alzheimer’s disease – current concepts

The clinical significance of 10-m walk test standardizations in Parkinson’s disease

Factors associated with fear of falling in people with Parkinson’s disease

Effects of certain pre-analytical factors on the performance of plasma phospho-tau217

Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease

Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer’s disease

Characterization of degradation and heterozygote balance by simulation of the forensic DNA analysis process

External validation of a 3-step falls prediction model in mild Parkinson’s disease

Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies

Novel insights regarding the measurement properties of the SCOPA-AUT

Towards a unified protocol for handling of CSF before β-amyloid measurements

Publisher Correction: Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies

Fluid biomarkers in Alzheimer’s disease – current concepts

The clinical significance of 10-m walk test standardizations in Parkinson’s disease

Factors associated with fear of falling in people with Parkinson’s disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Transgenic mice expressing a Huntington s disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Time of origin

Other Objects (12)

Effects of certain pre-analytical factors on the performance of plasma phospho-tau217

Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease

Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer’s disease

Characterization of degradation and heterozygote balance by simulation of the forensic DNA analysis process

External validation of a 3-step falls prediction model in mild Parkinson’s disease

Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies

Novel insights regarding the measurement properties of the SCOPA-AUT

Towards a unified protocol for handling of CSF before β-amyloid measurements

Publisher Correction: Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies

Fluid biomarkers in Alzheimer’s disease – current concepts

The clinical significance of 10-m walk test standardizations in Parkinson’s disease

Factors associated with fear of falling in people with Parkinson’s disease

Effects of certain pre-analytical factors on the performance of plasma phospho-tau217

Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease

Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer’s disease

Characterization of degradation and heterozygote balance by simulation of the forensic DNA analysis process

External validation of a 3-step falls prediction model in mild Parkinson’s disease

Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies

Novel insights regarding the measurement properties of the SCOPA-AUT

Towards a unified protocol for handling of CSF before β-amyloid measurements

Publisher Correction: Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies

Fluid biomarkers in Alzheimer’s disease – current concepts

The clinical significance of 10-m walk test standardizations in Parkinson’s disease

Factors associated with fear of falling in people with Parkinson’s disease

Effects of certain pre-analytical factors on the performance of plasma phospho-tau217

Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease

Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer’s disease

Characterization of degradation and heterozygote balance by simulation of the forensic DNA analysis process

External validation of a 3-step falls prediction model in mild Parkinson’s disease

Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies

Novel insights regarding the measurement properties of the SCOPA-AUT

Towards a unified protocol for handling of CSF before β-amyloid measurements

Publisher Correction: Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies

Fluid biomarkers in Alzheimer’s disease – current concepts

The clinical significance of 10-m walk test standardizations in Parkinson’s disease

Factors associated with fear of falling in people with Parkinson’s disease

Related objects

Reset password